SpringWorks Therapeutics (SWTX) News Today $34.63 -0.96 (-2.70%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Consensus Recommendation of "Buy" by BrokeragesShares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) have been given an average recommendation of "Buy" by the six ratings firms that are covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objJanuary 20 at 4:37 AM | marketbeat.comSpringWorks Therapeutics' SWOT analysis: biotech stock shows promise amid challengesJanuary 17 at 1:23 AM | msn.comSpringWorks Therapeutics (NASDAQ:SWTX) Trading Down 6.4% - Time to Sell?SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 6.4% - Here's What HappenedJanuary 16, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Up 4.3% - Should You Buy?SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Up 4.3% - What's Next?January 16, 2025 | marketbeat.comWedbush Has Positive Outlook of SWTX FY2024 EarningsSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) - Equities researchers at Wedbush lifted their FY2024 earnings per share estimates for shares of SpringWorks Therapeutics in a research note issued to investors on Monday, January 13th. Wedbush analyst D. Nierengarten now anticipates thatJanuary 16, 2025 | marketbeat.comWedbush Issues Pessimistic Estimate for SWTX EarningsJanuary 16, 2025 | americanbankingnews.comSpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap Down - Should You Sell?SpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap Down - What's Next?January 15, 2025 | marketbeat.comWedbush Brokers Decrease Earnings Estimates for SWTXSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) - Investment analysts at Wedbush decreased their FY2027 earnings per share estimates for shares of SpringWorks Therapeutics in a report released on Monday, January 13th. Wedbush analyst D. Nierengarten now forecasts that the company willJanuary 15, 2025 | marketbeat.comBank of America Securities Remains a Buy on Springworks Therapeutics (SWTX)January 15, 2025 | markets.businessinsider.comJPMorgan Chase & Co. Lowers Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)JPMorgan Chase & Co. lowered its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 9.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 255,052 shares of the company's stock after selling 25,074 shareJanuary 15, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Earns Outperform Rating from WedbushJanuary 15, 2025 | americanbankingnews.comenGene (NASDAQ:ENGN) and SpringWorks Therapeutics (NASDAQ:SWTX) Head-To-Head ReviewJanuary 15, 2025 | americanbankingnews.comSpringworks Therapeutics (SWTX) Receives a Buy from BarclaysJanuary 14, 2025 | markets.businessinsider.comSpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 6.4% - Time to Sell?SpringWorks Therapeutics (NASDAQ:SWTX) Trading Down 6.4% - What's Next?January 14, 2025 | marketbeat.comTD sees ‘some disappointment’ with lack of SpringWorks Therapeutics M&A newsJanuary 14, 2025 | markets.businessinsider.comBuy Rating Affirmed for Springworks Therapeutics: Strong Product Potential and Strategic Growth OutlookJanuary 14, 2025 | markets.businessinsider.comWedbush Reiterates "Outperform" Rating for SpringWorks Therapeutics (NASDAQ:SWTX)Wedbush reissued an "outperform" rating and set a $77.00 price objective on shares of SpringWorks Therapeutics in a report on Monday.January 13, 2025 | marketbeat.comSpringWorks Therapeutics Expects Ogsiveo Revenue To Be $61.5 Mln For Q4January 13, 2025 | markets.businessinsider.comSpringWorks Therapeutics dips 12%, gives prelim Q4 and FY topline estimatesJanuary 13, 2025 | msn.comSpringWorks Therapeutics Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 13, 2025 | globenewswire.comSpringWorks: PDUFA Review Date Could Lead To Next Approved Pipeline CandidateJanuary 13, 2025 | seekingalpha.comSpringWorks Therapeutics (NASDAQ:SWTX) Given New $78.00 Price Target at GuggenheimJanuary 11, 2025 | americanbankingnews.comSpringWorks Therapeutics price target lowered to $78 from $80 at GuggenheimJanuary 9, 2025 | markets.businessinsider.comGuggenheim Cuts SpringWorks Therapeutics (NASDAQ:SWTX) Price Target to $78.00Guggenheim lowered their price objective on SpringWorks Therapeutics from $80.00 to $78.00 and set a "buy" rating on the stock in a research note on Wednesday.January 8, 2025 | marketbeat.comSpringWorks Therapeutics (NASDAQ:SWTX) Trading 6.8% Higher - Time to Buy?SpringWorks Therapeutics (NASDAQ:SWTX) Trading 6.8% Higher - Time to Buy?January 7, 2025 | marketbeat.comSpringWorks Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 3, 2025 | globenewswire.comSpringWorks: With Catalyst On The Horizon And Growing Sales, 2025 Looks GreatDecember 31, 2024 | seekingalpha.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Consensus Rating of "Buy" by BrokeragesSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) has earned a consensus rating of "Buy" from the six analysts that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 1-year price target among anaDecember 26, 2024 | marketbeat.comPrincipal Financial Group Inc. Has $29.43 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Principal Financial Group Inc. raised its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 102.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 918,445 shares of theDecember 25, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Springworks Therapeutics (SWTX)December 24, 2024 | markets.businessinsider.comGeode Capital Management LLC Has $53.53 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Geode Capital Management LLC lifted its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 7.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,670,247December 23, 2024 | marketbeat.comBarclays PLC Purchases 58,645 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Barclays PLC lifted its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 60.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 155,676 shares of the company's stock aftDecember 21, 2024 | marketbeat.comTarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 PicksDecember 15, 2024 | seekingalpha.comLord Abbett & CO. LLC Has $34.27 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Lord Abbett & CO. LLC decreased its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 48.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,069,738 shares of the company's stock after sellingDecember 15, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 12.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 99,737 shares of the company's sDecember 14, 2024 | marketbeat.comMain Management ETF Advisors LLC Makes New $746,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Main Management ETF Advisors LLC acquired a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 23,280 shares of the companyDecember 8, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Increases Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Charles Schwab Investment Management Inc. increased its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 13.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 602,227 shares of thDecember 7, 2024 | marketbeat.comBadreddin Edris Sells 20,000 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) StockDecember 6, 2024 | insidertrades.comSoros Fund Management LLC Buys 174,321 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Soros Fund Management LLC increased its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 45.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 559,321 shares of the company's stock after acquiring an addDecember 6, 2024 | marketbeat.comErste Asset Management GmbH Makes New $397,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Erste Asset Management GmbH acquired a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 12,300 shares of the company's stock, valued at approxDecember 5, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Purchases 162,137 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)The Manufacturers Life Insurance Company raised its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 131.4% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 285,555 shares of the company's stock after purchasing an additionalDecember 4, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by HighVista Strategies LLCHighVista Strategies LLC lowered its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 29.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,852 shares oDecember 3, 2024 | marketbeat.comWalleye Capital LLC Grows Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Walleye Capital LLC raised its holdings in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 2,439.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 286,093 shares of the company's stocDecember 1, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Rating of "Buy" from AnalystsSpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Get Free Report) has earned an average recommendation of "Buy" from the six brokerages that are presently covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target amoDecember 1, 2024 | marketbeat.comSpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by Fmr LLCFmr LLC grew its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 0.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,140,946 shares of the company's stock after buyDecember 1, 2024 | marketbeat.comIntech Investment Management LLC Acquires New Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Intech Investment Management LLC bought a new stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 21,084 shares of the company's stock, valued at apprDecember 1, 2024 | marketbeat.comDynamic Technology Lab Private Ltd Makes New $439,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Dynamic Technology Lab Private Ltd bought a new position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 13,717 shares of the company's stock, valued at approximatNovember 30, 2024 | marketbeat.comAlly Bridge Group NY LLC Makes New Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Ally Bridge Group NY LLC purchased a new stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 227,700 shares of the company's stock, vNovember 28, 2024 | marketbeat.comSpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx ConferenceNovember 26, 2024 | globenewswire.comMassachusetts Financial Services Co. MA Has $20.61 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)Massachusetts Financial Services Co. MA raised its holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX - Free Report) by 20.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 643,192 shares of the company's stock after buyiNovember 26, 2024 | marketbeat.com Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address SWTX Media Mentions By Week SWTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SWTX News Sentiment▼0.300.44▲Average Medical News Sentiment SWTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SWTX Articles This Week▼224▲SWTX Articles Average Week Get SpringWorks Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Qiagen News Today Vaxcyte News Today Ascendis Pharma A/S News Today Roivant Sciences News Today Revolution Medicines News Today Lantheus News Today Blueprint Medicines News Today BridgeBio Pharma News Today Legend Biotech News Today Elanco Animal Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SWTX) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SWTX Stock Alerts